2.00 EUR
49.41 M EUR
741.17 M EUR
8.80 M
About NEURONES
Sector
CEO
Luc de Chammard
Website
Headquarters
Nanterre
Founded
1985
ISIN
FR0004050250
FIGI
BBG000CV9MR0
Neurones SA engages in the provision of consulting and digital services. The company operates through the following segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure Services segment includes service desk, workstation outsourcing, server and application outsourcing in cloud, computing mode, IT security, IT operations, IT service management, and IT governance. The Application Services segment comprises of IT consulting for finance, SAP integration and outsourcing, IT training and working with change, and mobile applications. The Consulting segment provides management, digital marketing, and organization consulting. The company was founded by Luc de Chammard on December 5, 1984 and is headquartered in Nanterre, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NRO is 45.40 EUR — it has increased by 0.89% in the past 24 hours. Watch NEURONES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange NEURONES stocks are traded under the ticker NRO.
NRO stock has risen by 0.89% compared to the previous week, the month change is a −5.12% fall, over the last year NEURONES has showed a 21.07% increase.
We've gathered analysts' opinions on NEURONES future price: according to them, NRO price has a max estimate of 50.00 EUR and a min estimate of 50.00 EUR. Watch NRO chart and read a more detailed NEURONES stock forecast: see what analysts think of NEURONES and suggest that you do with its stocks.
NRO stock is 1.00% volatile and has beta coefficient of 0.76. Track NEURONES stock price on the chart and check out the list of the most volatile stocks — is NEURONES there?
Yes, you can track NEURONES financials in yearly and quarterly reports right on TradingView.
NRO net income for the last half-year is 24.50 M EUR, while the previous report showed 23.99 M EUR of net income which accounts for 2.13% change. Track more NEURONES financial stats to get the full picture.
Yes, NRO dividends are paid annually. The last dividend per share was 1.20 EUR. As of today, Dividend Yield (TTM)% is 2.64%. Tracking NEURONES dividends might help you take more informed decisions.
NEURONES dividend yield was 2.74% in 2023, and payout ratio reached 58.87%. The year before the numbers were 2.80% and 60.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 6.75 K employees. See our rating of the largest employees — is NEURONES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEURONES EBITDA is 88.48 M EUR, and current EBITDA margin is 12.01%. See more stats in NEURONES financial statements.
Like other stocks, NRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEURONES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEURONES technincal analysis shows the neutral today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEURONES stock shows the buy signal. See more of NEURONES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.